Displaying items by tag: Cleveland Clinic's Taussig Cancer Institute

Cleveland Clinic researchers have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

Published in Experts